Identified from a screen of compounds that reactivate the transcriptional activity of wild-type p53 in mutp53, the small molecule RETRA can release p73 from the mutp53/p73 complex, resulting in the tumor-suppressive effect similar to the functional reactivation of p53 (Kravchenko et al., 2008). Here, TP53 is linked to neoplasm.